Aro Biotherapeutics

Aro Biotherapeutics

Biotechnology, 3675 Market St Ste 200, Philadelphia, Pennsylvania, 19104, United States, 11-50 Employees

arobiotx.com

  • twitter
  • LinkedIn

phone no Phone Number: 31********

Who is ARO BIOTHERAPEUTICS

Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a p...

Read More

map
  • 3675 Market St Ste 200, Philadelphia, Pennsylvania, 19104, United States Headquarters: 3675 Market St Ste 200, Philadelphia, Pennsylvania, 19104, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from ARO BIOTHERAPEUTICS

Aro Biotherapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Aro Biotherapeutics

Answer: Aro Biotherapeutics's headquarters are located at 3675 Market St Ste 200, Philadelphia, Pennsylvania, 19104, United States

Answer: Aro Biotherapeutics's phone number is 31********

Answer: Aro Biotherapeutics's official website is https://arobiotx.com

Answer: Aro Biotherapeutics's revenue is $1 Million to $5 Million

Answer: Aro Biotherapeutics's SIC: 2834

Answer: Aro Biotherapeutics has 11-50 employees

Answer: Aro Biotherapeutics is in Biotechnology

Answer: Aro Biotherapeutics contact info: Phone number: 31******** Website: https://arobiotx.com

Answer: Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access